alcohol dehydrogenase

alcohol dehydrogenase is a family of enzymes that catalyze the oxidation of primary and secondary alcohols to aldehydes and ketones using cofactors such as Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate and often coordinating metal ions like Zinc. First characterized in studies linked to metabolism in organisms investigated by researchers at institutions including University of Cambridge and Harvard University, these enzymes play central roles in metabolic pathways studied by scientists at Max Planck Society and have been subjects in biochemical research linked to work at the National Institutes of Health and the Salk Institute.

Structure and Mechanism

The catalytic architecture of these enzymes was elucidated through crystallography efforts involving laboratories at Massachusetts Institute of Technology, Stanford University, and the European Molecular Biology Laboratory, revealing a conserved catalytic pocket that binds Nicotinamide adenine dinucleotide and positions substrates via interactions with metal cofactors such as Zinc. Structural studies by teams associated with University of Oxford and University of California, San Francisco demonstrated how protein folds derived from the medium-chain dehydrogenase/reductase superfamily accommodate different substrates, and how conformational changes couple to hydride transfer steps described in mechanistic work from groups at ETH Zurich and Johns Hopkins University. High-resolution models obtained at facilities including the Diamond Light Source and the European Synchrotron Radiation Facility clarified residues coordinating metal ions and clarified transition-state stabilization, extending analyses common to enzyme kinetics approaches developed at University of Chicago.

Types and Isozymes

Multiple classes of these enzymes have been characterized across taxa, including the classical zinc-dependent enzymes prominent in animals and plants studied at University of Tokyo and University of Melbourne, and the iron- or manganese-dependent enzymes found in bacteria characterized by researchers at California Institute of Technology and Woods Hole Oceanographic Institution. Mammalian isozymes—extensively profiled by research groups at Yale University and the University of Cambridge—include several gene products with tissue-specific expression that have been mapped through projects coordinated by the Wellcome Trust and the Human Genome Project. Microbial variants, studied by investigators at Max Planck Institute for Terrestrial Microbiology and Scripps Institution of Oceanography, show broad substrate scope and oligomeric diversity, while thermophilic and extremophilic forms characterized by teams at University of Birmingham and Lawrence Berkeley National Laboratory exhibit adaptations elucidated through comparative genomics initiated at European Bioinformatics Institute.

Biological Roles and Distribution

These enzymes mediate metabolic fluxes in pathways such as ethanol metabolism in liver tissue investigated at Mayo Clinic and fermentation pathways in yeast strains used by laboratories at University of Leuven and breweries like Anheuser-Busch for applied studies. In microbial ecology, variants contribute to biodegradation and carbon cycling in environments sampled by expeditions organized by National Oceanic and Atmospheric Administration and research stations supported by Smithsonian Institution, while plant forms participate in secondary metabolism explored by researchers at Kew Gardens and agricultural programs at Iowa State University. Evolutionary distribution mapped by consortia including Joint Genome Institute and Broad Institute shows gene family expansions and horizontal gene transfer events discussed in comparative studies involving University of Copenhagen and University of Toronto.

Clinical Significance and Genetic Variants

Genetic polymorphisms in specific gene families encoding these enzymes have been linked to differential alcohol metabolism phenotypes identified in population studies led by investigators at Centers for Disease Control and Prevention and clinical cohorts at Johns Hopkins Hospital. Variants associated with altered enzymatic activity were characterized in genetic epidemiology studies at National Human Genome Research Institute and have clinical implications for susceptibility to conditions investigated at Cleveland Clinic and pharmacogenomics programs at Mayo Clinic Arizona. Pathogenic mutations affecting enzyme function have been assessed in biochemical genetics laboratories at Great Ormond Street Hospital and therapeutic research initiatives at University College London exploring impacts on metabolic disorders and interactions with medications monitored by regulatory agencies such as the Food and Drug Administration.

Industrial and Biotechnological Applications

Applied research translating enzyme properties into biocatalysis has been conducted by industrial groups at Novozymes and academic collaborations with Imperial College London and ETH Zurich, enabling stereo- and regioselective oxidations used in synthesis for pharmaceutical companies like Pfizer and Roche. Engineering efforts using directed evolution performed in laboratories at Ecole Polytechnique Fédérale de Lausanne and University of California, Berkeley have yielded variants optimized for solvent tolerance and altered cofactor specificity, facilitating scalable processes adopted by biotechnology firms including Genentech and DSM. Environmental biotechnology projects run by agencies such as United States Geological Survey deploy microbial strains or immobilized enzymes for bioremediation, while synthetic biology initiatives at MIT and start-ups incubated at Cambridge Innovation Center harness these enzymes in metabolic pathways for biofuel and fine-chemical production.

Category:Enzymes